Cancer and COVID-19 vaccines: a complex global picture
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Patients with cancer can be at high risk of severe COVID-19 due to their age, disease, cancer treatment, and medical co-morbidities.1 The pandemic has also led to substantial disruptions to diagnosis and treatment in many parts of the world.2, 3 Patients with cancer in low-income and middle-income countries (LMICs) are further disadvantaged compared with those in high-income settings because of unequal access to COVID-19 vaccines in already fragile health-care systems.
The Lancet Oncology , commentaire en libre accès, 2020